Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02770027
Other study ID # KUH000013
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2020
Est. completion date December 2021

Study information

Verified date January 2020
Source Konkuk University Medical Center
Contact Tae-Yop Kim, MD, PhD
Phone 82-2-2030-5448
Email taeyop@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After obtaining approval from the Institutional Review Board of our institution, written informed consent is obtained from patients undergoing colon surgery are enrolled in this prospective study and randomly allocated into one of two groups: Group-C (n=15) and Group-HES (n=15).

All recruited patients will be given patient identification number (PIN) for the present study of 01-30 according to their order of interview and recruitment. Investigators will prepare 15 yellow and 15 green cards, which will be inserted in 30 thick-paper envelopes. Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 30 (Envelop number).

According to the color of the card, attending anesthesiologists will give crystalloid for yellow card or HES for green cards, respectively, to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture.

Patient data and statistical analyses:

Patient's data whole blood viscosity, PaO2, FiO2, Hemoglobin, urine amount, s-glucose will be determined from the patients' medical record after patient's discharge.

All statistical analyses will be performed after the 30th patient's discharge and data acquisition


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 2021
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing colon surgery

- Patients provided a written informed consent.

- Patients with preoperative serum hemoglobin concentration >13 g/dL (male) and >12 g/dL (female)

- Patients with PaO2/FiO2 ratio >150

Exclusion Criteria:

- Patients with history of anemia, dyspnea, active infection.

- Patients with endocrine disease

- Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, anti-platelet drug, anti-fibrinolytic agents or recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Intravenous Crystalloid
Crystalloid is administered to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture
Intravenous HES
HES is administered to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Konkuk University Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary whole blood viscosity whole blood viscosity measured by viscometer cm-1 with 1 hour after the completion of procedure
Secondary PaO2/FiO2 ratio PaO2/FiO2 ratio measured by arterial blood gas analysis 1 hour after the completion of procedure
Secondary hematocrit serum hematocrit, % 1 hour after the completion of procedure
Secondary glucose serum glucose level, g/dl 1 hour after the completion of procedure
Secondary osmolarity serum osmolarity, mOsm 1 hour after the completion of procedure
Secondary urine output hourly urine output, ml/hr 1 hour after the completion of procedure
Secondary Maximum clot formation Maximum clot formation in rotational thromboelastometry (ROTEM) analysis, mm 1 hour after the completion of procedure
See also
  Status Clinical Trial Phase
Completed NCT00722709 - Intraperitoneal Local Anaesthetic in Colonic Surgery Phase 1
Completed NCT03633123 - D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection Phase 2
Completed NCT05681338 - Effect of the Coughing Technique During Subcutaneous Heparin Injection N/A
Completed NCT06020768 - The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position N/A
Completed NCT04233424 - D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection Phase 3
Completed NCT05981937 - ICG Anastomosis Control in Colon Surgery
Completed NCT01995591 - Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer N/A
Recruiting NCT04411199 - D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II) Phase 3